论文部分内容阅读
转化生长因子-β(TGF-β)属于TGF-β超家族中的一员，在多个生物进程中发挥作用，包括细胞增殖、分化、迁移及组织纤维化等。正常情况下，TGF-β广泛表达于正常组织和大多数细胞系，如巨噬细胞和树突状细胞等，但在病理情况下，肿瘤细胞和肿瘤相关成纤维细胞也可产生并分泌TGF-β。硬化性胃癌(SGC)是一种特殊类型的胃癌亚型，发展快、腹膜种植多见，并伴随明显的间质纤维化沉积，这些生物学行为特点提示其发生、发展与TGF-β的表达有着密切的关系，并且TGF-β被认为与SGC的不良预后有关。使用TGF-β及其信号通路的抗体及抑制剂，可降低癌细胞的侵袭性，从而改善SGC患者预后。本文试就TGF-β在SGC中的表达和意义研究状况作一综述。“,”Transforming growth factor-β(TGF-β), a member of the TGF-β superfamily, plays a role in multiple biological processes, including cell proliferation, differentiation, migration and tissue fibrosis, etc. Normally, TGF-βs widely express in normal tissues and most cell lines, such as macrophages and dendritic cells, But in pathological conditions, Cancer cells and cancer-associated fibroblasts also produce and secrete TGF-β. Scirrhous gastric cancer (SGC) is a special subtype of gastric cancer with rapid development, frequent peritoneal implantation, and accompanied by significant interstitial fibrosis deposition. these biological behavior characteristics all suggest that its occurrence and development are closely related to TGF-β expression, and TGF-β is considered to be associated with poor prognosis of the SGC. The use of antibodies and inhibitors of TGF-β and its signaling pathways can reduce the invasiveness of cancer cells and improve the prognosis of SGC patients. This paper reviews the expression and significance of TGF-β in SGC.